Gossamer Bio Files New Drug Application for Seralutinib
MT newswire2026/09/23 21:11Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
05:11 PM EDT, 09/23/2026 (MT Newswires) -- Gossamer Bio (GOSS) said late Wednesday it has submitted a new drug application to the US Food and Drug Administration for seralutinib to treat pulmonary arterial hypertension. The FDA will determine whether to accept the filing following its initial review of the application, which could occur later this year, the clinical-stage biopharmaceutical company said.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
How Much Is a Variational Airdrop Point Worth After the $1.5 Billion Raise?
BeInCrypto•2026/11/19 10:15
BUZZ-Anthropic receives 'Outperform' rating from Needham ahead of IPO
路透社•2026/11/19 10:08
Crypto prices
MoreBitcoin
BTC
$63,771.68
-1.16%
Ethereum
ETH
$1,805.14
-0.24%
Tether USDt
USDT
$0.9988
+0.00%
BNB
BNB
$589.56
-0.21%
USDC
USDC
$0.9998
-0.00%
XRP
XRP
$0.9826
-1.95%
Solana
SOL
$74.45
-0.71%
TRON
TRX
$0.3118
+1.11%
Hyperliquid
HYPE
$68.41
-0.40%
Zcash
ZEC
$945.94
-0.06%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now